Fore Bio Puts Plixorafenib Strategy Before Investors
PHILADELPHIA, PA — Fore Biotherapeutics will present its corporate strategy at the Morgan Stanley 24th Annual Global Healthcare Conference on Sept. 15, putting its lead cancer drug plixorafenib before investors …
Fore Bio Puts Plixorafenib Strategy Before Investors Read More